Skip to main content

5 Result(s)

within V. Andreasi Remove this filter

and

  1. No Access

    Article

    68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours

    To explore the role of fully hybrid 68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine tumours (PanNETs) undergoing s...

    P. Mapelli, C. Bezzi, D. Palumbo… in European Journal of Nuclear Medicine and M… (2022)

  2. No Access

    Article

    Role of chromogranin A-derived fragments after resection of nonfunctioning pancreatic neuroendocrine tumors

    No single reliable biomarker is available for nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs). Vasostatin-1 (VS-1), the N-terminal fragment of chromogranin A (CgA), seems to be a more accurate bio...

    V. Andreasi, S. Partelli, M. F. Manzoni… in Journal of Endocrinological Investigation (2022)

  3. No Access

    Article

    Predictors of disease recurrence after curative surgery for nonfunctioning pancreatic neuroendocrine neoplasms (NF-PanNENs): a systematic review and meta-analysis

    Patients submitted to curative surgery for non-functioning pancreatic neuroendocrine neoplasms (NF-PanNENs) exhibit a variable risk of disease relapse. Aims of this meta-analysis were to estimate the rate of d...

    V. Andreasi, C. Ricci, S. Partelli… in Journal of Endocrinological Investigation (2022)

  4. No Access

    Article

    Risk of preoperative understaging of duodenal neuroendocrine neoplasms: a plea for caution in the treatment strategy

    Pretreatment staging is the milestone for planning either surgical or endoscopic treatment in duodenal neuroendocrine neoplasms (dNENs). Herein, a series of surgically treated dNEN patients was evaluated to as...

    R. E. Rossi, A. C. Milanetto, V. Andreasi… in Journal of Endocrinological Investigation (2021)

  5. No Access

    Article

    68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks

    PET with radiolabeled somatostatin receptors (SSTR) analogues, such as 68Ga-DOTATOC, is commonly used in all stages of gastroenteropancreatic neuroendocrine tumours (GEP-NETs). Magnetic resonance Imaging (MRI) ha...

    P. Mapelli, G. Ironi, F. Fallanca, S. Partelli… in Clinical and Translational Imaging (2019)